메뉴 건너뛰기




Volumn 34, Issue 6, 2010, Pages 945-954

A parametric study of the acute effects of antipsychotic drugs on glucose sensitivity in an animal model

Author keywords

Clozapine; Haloperidol; Metabolic; Olanzapine; Rat; Risperidone

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; GLUCOSE; HALOPERIDOL; INSULIN; OLANZAPINE; RISPERIDONE; GLUCOSE BLOOD LEVEL; NEUROLEPTIC AGENT;

EID: 77955053755     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.04.024     Document Type: Article
Times cited : (68)

References (39)
  • 1
    • 77955048946 scopus 로고    scopus 로고
    • AHA. Metabolic syndrome: new guidance for prevention and treatment. AHA and NHLBI Scientific Statement.
    • AHA. Metabolic syndrome: new guidance for prevention and treatment. AHA and NHLBI Scientific Statement 2005.
    • (2005)
  • 3
    • 0033361056 scopus 로고    scopus 로고
    • Pharmacokinetics and tissue distribution of olanzapine in rats
    • Aravagiri M., Teper Y., Marder S.R. Pharmacokinetics and tissue distribution of olanzapine in rats. Biopharm Drug Dispos 1999, 20:369-377.
    • (1999) Biopharm Drug Dispos , vol.20 , pp. 369-377
    • Aravagiri, M.1    Teper, Y.2    Marder, S.R.3
  • 4
    • 49749133879 scopus 로고    scopus 로고
    • The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063
    • Assie M.B., Carilla-Durand E., Bardin L., Maraval M., Aliaga M., Malfetes N., et al. The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063. Eur J Pharmacol 2008, 592:160-166.
    • (2008) Eur J Pharmacol , vol.592 , pp. 160-166
    • Assie, M.B.1    Carilla-Durand, E.2    Bardin, L.3    Maraval, M.4    Aliaga, M.5    Malfetes, N.6
  • 6
    • 57049134614 scopus 로고    scopus 로고
    • Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats
    • Cacho J., Sevillano J., de Castro J., Herrera E., Ramos M.P. Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats. Am J Physiol Endocrinol Metab 2008, 295:E1269-E1276.
    • (2008) Am J Physiol Endocrinol Metab , vol.295
    • Cacho, J.1    Sevillano, J.2    de Castro, J.3    Herrera, E.4    Ramos, M.P.5
  • 7
    • 0026564595 scopus 로고
    • Linear pharmacokinetics of haloperidol in the rat
    • Cheng Y.F., Paalzow L.K. Linear pharmacokinetics of haloperidol in the rat. Biopharm Drug Dispos 1992, 13:69-76.
    • (1992) Biopharm Drug Dispos , vol.13 , pp. 69-76
    • Cheng, Y.F.1    Paalzow, L.K.2
  • 8
    • 58149109332 scopus 로고    scopus 로고
    • Insulin resistance and decreased glucose-stimulated insulin secretion after acute olanzapine administration
    • Chintoh A.F., Mann S.W., Lam L., Lam C., Cohn T.A., Fletcher P.J., et al. Insulin resistance and decreased glucose-stimulated insulin secretion after acute olanzapine administration. J Clin Psychopharmacol 2008, 28:494-499.
    • (2008) J Clin Psychopharmacol , vol.28 , pp. 494-499
    • Chintoh, A.F.1    Mann, S.W.2    Lam, L.3    Lam, C.4    Cohn, T.A.5    Fletcher, P.J.6
  • 9
    • 50249172922 scopus 로고    scopus 로고
    • Insulin resistance following continuous, chronic olanzapine treatment: an animal model
    • Chintoh A.F., Mann S.W., Lam T.K., Giacca A., Remington G. Insulin resistance following continuous, chronic olanzapine treatment: an animal model. Schizophr Res 2008, 104:23-30.
    • (2008) Schizophr Res , vol.104 , pp. 23-30
    • Chintoh, A.F.1    Mann, S.W.2    Lam, T.K.3    Giacca, A.4    Remington, G.5
  • 10
    • 60249097928 scopus 로고    scopus 로고
    • Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model
    • Chintoh A.F., Mann S.W., Lam L., Giacca A., Fletcher P., Nobrega J., et al. Insulin resistance and secretion in vivo: effects of different antipsychotics in an animal model. Schizophr Res 2009, 108:127-133.
    • (2009) Schizophr Res , vol.108 , pp. 127-133
    • Chintoh, A.F.1    Mann, S.W.2    Lam, L.3    Giacca, A.4    Fletcher, P.5    Nobrega, J.6
  • 11
    • 34447575781 scopus 로고    scopus 로고
    • Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities
    • Cooper G.D., Pickavance L.C., Wilding J.P., Harrold J.A., Halford J.C., Goudie A.J. Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities. J Psychopharmacol 2007, 21:405-413.
    • (2007) J Psychopharmacol , vol.21 , pp. 405-413
    • Cooper, G.D.1    Pickavance, L.C.2    Wilding, J.P.3    Harrold, J.A.4    Halford, J.C.5    Goudie, A.J.6
  • 12
    • 38749111141 scopus 로고    scopus 로고
    • Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain
    • Cooper G.D., Harrold J.A., Halford J.C., Goudie A.J. Chronic clozapine treatment in female rats does not induce weight gain or metabolic abnormalities but enhances adiposity: implications for animal models of antipsychotic-induced weight gain. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:428-436.
    • (2008) Prog Neuropsychopharmacol Biol Psychiatry , vol.32 , pp. 428-436
    • Cooper, G.D.1    Harrold, J.A.2    Halford, J.C.3    Goudie, A.J.4
  • 13
    • 33748786233 scopus 로고    scopus 로고
    • Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with second-generation antipsychotic agents
    • Elman I., Borsook D., Lukas S.E. Food intake and reward mechanisms in patients with schizophrenia: implications for metabolic disturbances and treatment with second-generation antipsychotic agents. Neuropsychopharmacology 2006, 31:2091-2120.
    • (2006) Neuropsychopharmacology , vol.31 , pp. 2091-2120
    • Elman, I.1    Borsook, D.2    Lukas, S.E.3
  • 14
    • 34648835121 scopus 로고    scopus 로고
    • The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats
    • Fell M.J., Anjum N., Dickinson K., Marshall K.M., Peltola L.M., Vickers S., et al. The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats. Psychopharmacology (Berl) 2007, 194:221-231.
    • (2007) Psychopharmacology (Berl) , vol.194 , pp. 221-231
    • Fell, M.J.1    Anjum, N.2    Dickinson, K.3    Marshall, K.M.4    Peltola, L.M.5    Vickers, S.6
  • 15
    • 0034917841 scopus 로고    scopus 로고
    • Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review
    • Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 2001, 156:117-154.
    • (2001) Psychopharmacology (Berl) , vol.156 , pp. 117-154
    • Geyer, M.A.1    Krebs-Thomson, K.2    Braff, D.L.3    Swerdlow, N.R.4
  • 16
    • 0031727960 scopus 로고    scopus 로고
    • Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guinea pig, ferret and mink
    • Hem A., Smith A.J., Solberg P. Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guinea pig, ferret and mink. Lab Anim 1998, 32:364-368.
    • (1998) Lab Anim , vol.32 , pp. 364-368
    • Hem, A.1    Smith, A.J.2    Solberg, P.3
  • 17
    • 35648948443 scopus 로고    scopus 로고
    • Weight gain with atypical antipsychotics: evidence and insights
    • Henderson D.C. Weight gain with atypical antipsychotics: evidence and insights. J Clin Psychiatry 2007, 68(Suppl 12):18-26.
    • (2007) J Clin Psychiatry , vol.68 , Issue.SUPPL 12 , pp. 18-26
    • Henderson, D.C.1
  • 18
    • 34548097526 scopus 로고    scopus 로고
    • Conceptual and methodological issues in the design of clinical trials of antipsychotics for the treatment of schizophrenia
    • Honer W.G., Thornton A.E., Sherwood M., MacEwan G.W., Ehmann T.S., Williams R., et al. Conceptual and methodological issues in the design of clinical trials of antipsychotics for the treatment of schizophrenia. CNS Drugs 2007, 21:699-714.
    • (2007) CNS Drugs , vol.21 , pp. 699-714
    • Honer, W.G.1    Thornton, A.E.2    Sherwood, M.3    MacEwan, G.W.4    Ehmann, T.S.5    Williams, R.6
  • 19
    • 33846264544 scopus 로고    scopus 로고
    • Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects
    • Houseknecht K.L., Robertson A.S., Zavadoski W., Gibbs E.M., Johnson D.E., Rollema H. Acute effects of atypical antipsychotics on whole-body insulin resistance in rats: implications for adverse metabolic effects. Neuropsychopharmacology 2007, 32:289-297.
    • (2007) Neuropsychopharmacology , vol.32 , pp. 289-297
    • Houseknecht, K.L.1    Robertson, A.S.2    Zavadoski, W.3    Gibbs, E.M.4    Johnson, D.E.5    Rollema, H.6
  • 20
    • 0032821965 scopus 로고    scopus 로고
    • Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp
    • Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diab Care 1999, 22:1462-1470.
    • (1999) Diab Care , vol.22 , pp. 1462-1470
    • Matsuda, M.1    DeFronzo, R.A.2
  • 21
    • 0842328609 scopus 로고    scopus 로고
    • Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro
    • Melkersson K. Clozapine and olanzapine, but not conventional antipsychotics, increase insulin release in vitro. Eur Neuropsychopharmacol 2004, 14:115-119.
    • (2004) Eur Neuropsychopharmacol , vol.14 , pp. 115-119
    • Melkersson, K.1
  • 22
    • 37849041094 scopus 로고    scopus 로고
    • Effects of the atypical antipsychotic clozapine on insulin release in vitro
    • Melkersson K., Jansson E. Effects of the atypical antipsychotic clozapine on insulin release in vitro. Neuro Endocrinol Lett 2007, 28:854-860.
    • (2007) Neuro Endocrinol Lett , vol.28 , pp. 854-860
    • Melkersson, K.1    Jansson, E.2
  • 23
    • 0942287757 scopus 로고    scopus 로고
    • Evaluation of insulin sensitivity in clinical practice and in research settings
    • Monzillo L.U., Hamdy O. Evaluation of insulin sensitivity in clinical practice and in research settings. Nutr Rev 2003, 61:397-412.
    • (2003) Nutr Rev , vol.61 , pp. 397-412
    • Monzillo, L.U.1    Hamdy, O.2
  • 24
    • 38349006256 scopus 로고    scopus 로고
    • Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage
    • Muniyappa R., Lee S., Chen H., Quon M.J. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008, 294:E15-E26.
    • (2008) Am J Physiol Endocrinol Metab , vol.294
    • Muniyappa, R.1    Lee, S.2    Chen, H.3    Quon, M.J.4
  • 25
    • 34547546693 scopus 로고    scopus 로고
    • Acute administration of clozapine concurrently increases blood glucose and circulating plasma ghrelin levels in rats
    • Murashita M., Kusumi I., Hosoda H., Kangawa K., Koyama T. Acute administration of clozapine concurrently increases blood glucose and circulating plasma ghrelin levels in rats. Psychoneuroendocrinology 2007, 32:777-784.
    • (2007) Psychoneuroendocrinology , vol.32 , pp. 777-784
    • Murashita, M.1    Kusumi, I.2    Hosoda, H.3    Kangawa, K.4    Koyama, T.5
  • 26
    • 18744366088 scopus 로고    scopus 로고
    • Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review
    • Newcomer J.W. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005, 19(Suppl 1):1-93.
    • (2005) CNS Drugs , vol.19 , Issue.SUPPL 1 , pp. 1-93
    • Newcomer, J.W.1
  • 27
    • 34248562315 scopus 로고    scopus 로고
    • Antipsychotic medications: metabolic and cardiovascular risk
    • Newcomer J.W. Antipsychotic medications: metabolic and cardiovascular risk. J Clin Psychiatry 2007, 68(Suppl 4):8-13.
    • (2007) J Clin Psychiatry , vol.68 , Issue.SUPPL 4 , pp. 8-13
    • Newcomer, J.W.1
  • 28
    • 33750459719 scopus 로고    scopus 로고
    • Elevation of systolic blood pressure in an animal model of olanzapine induced weight gain
    • Patil B.M., Kulkarni N.M., Unger B.S. Elevation of systolic blood pressure in an animal model of olanzapine induced weight gain. Eur J Pharmacol 2006, 551:112-115.
    • (2006) Eur J Pharmacol , vol.551 , pp. 112-115
    • Patil, B.M.1    Kulkarni, N.M.2    Unger, B.S.3
  • 29
    • 34848827473 scopus 로고    scopus 로고
    • Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment
    • Procyshyn R.M., Wasan K.M., Thornton A.E., Barr A.M., Chen E.Y., Pomarol-Clotet E., et al. Changes in serum lipids, independent of weight, are associated with changes in symptoms during long-term clozapine treatment. J Psychiatry Neurosci 2007, 32:331-338.
    • (2007) J Psychiatry Neurosci , vol.32 , pp. 331-338
    • Procyshyn, R.M.1    Wasan, K.M.2    Thornton, A.E.3    Barr, A.M.4    Chen, E.Y.5    Pomarol-Clotet, E.6
  • 30
    • 77952633076 scopus 로고    scopus 로고
    • Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting. J Clin Psychiatry.
    • Procyshyn RM, Honer WG, Wu TKY, Ko RWY, McIsaac SA, Young AH, et al. Persistent antipsychotic polypharmacy and excessive dosing in the community psychiatric treatment setting. J Clin Psychiatry 2010;71(5):566-573.
    • (2010) , vol.71 , Issue.5 , pp. 566-573
    • Procyshyn, R.M.1    Honer, W.G.2    Wu, T.K.Y.3    Ko, R.W.Y.4    McIsaac, S.A.5    Young, A.H.6
  • 31
    • 33750077822 scopus 로고    scopus 로고
    • Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies
    • Ramaswamy K., Masand P.S., Nasrallah H.A. Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies. Ann Clin Psychiatry 2006, 18:183-194.
    • (2006) Ann Clin Psychiatry , vol.18 , pp. 183-194
    • Ramaswamy, K.1    Masand, P.S.2    Nasrallah, H.A.3
  • 32
    • 0033377929 scopus 로고    scopus 로고
    • Conventional versus novel antipsychotics: changing concepts and clinical implications
    • Remington G., Chong S.A. Conventional versus novel antipsychotics: changing concepts and clinical implications. J Psychiatry Neurosci 1999, 24:431-441.
    • (1999) J Psychiatry Neurosci , vol.24 , pp. 431-441
    • Remington, G.1    Chong, S.A.2
  • 33
    • 34447534307 scopus 로고    scopus 로고
    • Schizophrenia, antipsychotics and metabolic disease
    • Reynolds G.P. Schizophrenia, antipsychotics and metabolic disease. J Psychopharmacol 2007, 21:355-356.
    • (2007) J Psychopharmacol , vol.21 , pp. 355-356
    • Reynolds, G.P.1
  • 34
    • 0037317444 scopus 로고    scopus 로고
    • Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia
    • Ryan M.C., Collins P., Thakore J.H. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia. Am J Psychiatry 2003, 160:284-289.
    • (2003) Am J Psychiatry , vol.160 , pp. 284-289
    • Ryan, M.C.1    Collins, P.2    Thakore, J.H.3
  • 36
    • 55649115291 scopus 로고    scopus 로고
    • Atypical antipsychotic drugs induce derangements in glucose homeostasis by acutely increasing glucagon secretion and hepatic glucose output in the rat
    • Smith G.C., Chaussade C., Vickers M., Jensen J., Shepherd P.R. Atypical antipsychotic drugs induce derangements in glucose homeostasis by acutely increasing glucagon secretion and hepatic glucose output in the rat. Diabetologia 2008, 51:2309-2317.
    • (2008) Diabetologia , vol.51 , pp. 2309-2317
    • Smith, G.C.1    Chaussade, C.2    Vickers, M.3    Jensen, J.4    Shepherd, P.R.5
  • 37
    • 70349423412 scopus 로고    scopus 로고
    • Clozapine and quetiapine acutely reduce glucagon-like peptide-1 production and increase glucagon release in obese rats: implications for glucose metabolism and food choice behaviour
    • Smith G.C., Vickers M.H., Cognard E., Shepherd P.R. Clozapine and quetiapine acutely reduce glucagon-like peptide-1 production and increase glucagon release in obese rats: implications for glucose metabolism and food choice behaviour. Schiz Res 2009, 115:30-40.
    • (2009) Schiz Res , vol.115 , pp. 30-40
    • Smith, G.C.1    Vickers, M.H.2    Cognard, E.3    Shepherd, P.R.4
  • 38
    • 34248161538 scopus 로고    scopus 로고
    • Clozapine-induced alteration of glucose homeostasis in the rat: the contribution of hypothalamic-pituitary-adrenal axis activation
    • Tulipano G., Rizzetti C., Bianchi I., Fanzani A., Spano P., Cocchi D. Clozapine-induced alteration of glucose homeostasis in the rat: the contribution of hypothalamic-pituitary-adrenal axis activation. Neuroendocrinology 2007, 85:61-70.
    • (2007) Neuroendocrinology , vol.85 , pp. 61-70
    • Tulipano, G.1    Rizzetti, C.2    Bianchi, I.3    Fanzani, A.4    Spano, P.5    Cocchi, D.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.